β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1)
β -Hydroxyisovalerylshikonin ( β -HIVS), which was isolated from the plant, Lithospermum radix , induces apoptosis in various lines of human tumor cells. To identify genes involved in β -HIVS-induced apoptotic process, we performed cDNA array analysis and found that β -HIVS suppresses the expression...
Gespeichert in:
Veröffentlicht in: | Oncogene 2003-02, Vol.22 (7), p.1012-1023 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | β
-Hydroxyisovalerylshikonin (
β
-HIVS), which was isolated from the plant,
Lithospermum radix
, induces apoptosis in various lines of human tumor cells. To identify genes involved in
β
-HIVS-induced apoptotic process, we performed cDNA array analysis and found that
β
-HIVS suppresses the expression of the gene for a polo-like kinase 1 (PLK1) that is involved in control of the cell cycle. When U937 and HL60 cells were treated with 10
−6
M
β
-HIVS for 0.5 h, both the amount of PLK1 itself and the kinase activity of this enzyme were decreased. By contrast, Bcr–Abl-positive K562 cells were resistant to the induction of apoptosis by
β
-HIVS and this compound did not suppress the kinase activity of PLK1 in these cells. However, simultaneous treatment of K562 cells with both
β
-HIVS and STI571, which selectively inhibits the protein tyrosine kinase (PTK) activity of Bcr–Abl, strongly induced apoptosis. Moreover,
β
-HIVS increased the inhibitory effect of STI571 on PTK activity. Treatment of K562 cells with antisense oligodeoxynucleotides (ODNs) specific for PLK1 sensitized these cells to the
β
-HIVS-induced fragmentation of DNA. These results suggest that suppression of the activity of PLK1 via inhibition of tyrosine kinase activity by
β
-HIVS might play a critical role in the induction of apoptosis. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/sj.onc.1206200 |